Pembrolizumab for Early Triple-Negative Breast Cancer. Reply

N Engl J Med. 2020 Jun 25;382(26):e108. doi: 10.1056/NEJMc2006684.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Breast Neoplasms*
  • Humans
  • Triple Negative Breast Neoplasms*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab